This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Turner-Stokes, L. Articles by Hassan, N. Search for Related Content PubMed PubMed Citation Articles by Turner-Stokes, L. Articles by Hassan, N. Social Bookmarking                         What's this?

Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives

Nibras Hassan

Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK

Background: Depression is a common complication of stroke, leading to increased morbidity and mortality. It can impede the process of rehabilitation, and has been associated with poorer outcomes and increased length of stay in hospital.

This systematic review was undertaken as a preliminary step to the development of an evidence-based integrated care pathway (ICP) for the management of post-stroke depression (PSD) in a rehabilitation setting, and is divided into two parts. In part 1 we reviewed the frequency of depression in stroke, its impact on functional recovery and the different methods for assessment.

Aims and objectives: In part 2, we discuss the rationale for treatment of PSD, appraise the evidence for effectiveness of the different antidepressant drugs, and consider whether we can identify a recommended "rst-line treatment for use in our ICP.

Methods: Data sources comprised a computer-aided search of published studies on depression in stroke and references to literature used in reviews.

Main " ndings: From the few controlled trials of anti-depressant therapy in PSD, both tricyclics and selective serotonin re-uptake inhibitors (SSRIs) appear to be effective, but the latter may be preferable in stroke because of their prompt action and better side-effect pro"les. Within the group of SSRIs there is currently no direct evidence to guide the choice of agent. In the absence of "rm guidance, sertraline was chosen on theoretical grounds as one of the most potent with minimal sedative effects and no reported interaction with warfarin. Citalopram may offer an appropriate second choice.

Conclusions: A suggested regimen for the use of sertraline in PSD was put forward. Development of an ICP may help to establish a more consistent approach to assessment and treatment of PSD, and form a basis for future comparison of different treatments as they become available.

Clinical Rehabilitation, Vol. 16, No. 3, 248-260 (2002)
DOI: 10.1191/0269215502cr488oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. M. Knottnerus, T. Turner-Stokes, F.B. van de Weg, L. Heijnen, G.J. Lankhorst, and L. Turner-Stokes Diagnosis and treatment of depression following acquired brain injury: a comparison of practice in the UK and the Netherlands Clinical Rehabilitation, September 1, 2007; 21(9): 805 - 811. [Abstract] [PDF]

				N. Kotzailias, T. Andonovski, A. Dukic, V. L. Serebruany, and B. Jilma Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo-Controlled, Double-blind Trial. J. Clin. Pharmacol., April 1, 2006; 46(4): 468 - 475. [Abstract] [Full Text] [PDF]

				M. Dilley and S. Fleminger Advances in neuropsychiatry: clinical implications Adv. Psychiatr. Treat., January 1, 2006; 12(1): 23 - 34. [Abstract] [Full Text] [PDF]

				N. Hassan, L. Turner-Stokes, K. Pierce, and F. Clegg A completed audit cycle and integrated care pathway for the management of depression following brain injury in a rehabilitation setting Clinical Rehabilitation, May 1, 2002; 16(5): 534 - 540. [Abstract] [PDF]

				L. Turner-Stokes, N. Hassan, K. Pierce, and F. Clegg Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline Clinical Rehabilitation, March 1, 2002; 16(3): 261 - 268. [Abstract] [PDF]